Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Miguel Saps(University of Miami), Jeffrey S. Hyams(Connecticut Children's Medical Center), Susanna Y. Huh(Ironwood Pharmaceuticals (United States)), Julie Khlevner(Morgan Stanley Children's Hospital), Gerardo Rodriguez‐Araujo(Osaka University), Marc A. Benninga(Amsterdam University Medical Centers), Wangang Xie(AbbVie (United States)), Marcella E. Hewson(AbbVie (United States)), Masakazu Ando(Ironwood Pharmaceuticals (United States)), Samuel Nurko(Boston Children's Hospital), Michael W. Simon(University of Kentucky)
Cited by 31
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Childhood Functional Gastrointestinal Disorders: Neonate/Toddler
|Gastroenterology|2016|1.1k
Evaluation and Treatment of Functional Constipation in Infants and Children
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.1k